Nosocomial infections due to Acinetobacter species: Clinical findings, risk and prognostic factors

Indian Journal of Medical Microbiology

Volumn 24, Issue 1, 2006, Pages 39-44

  Prashanth, K ^a   Badrinath, S ^b  

^a CENTRE FOR DNA FINGERPRINTING AND DIAGNOSTICS   (India)

^b JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Acinetobacter species; Multiple drug resistance; Nosocomial infection; Risk and prognostic factors

Indexed keywords

AMIKACIN; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HOSPITAL INFECTION; HUMAN; INFANT; INFECTION RISK; MALE; MORTALITY; MULTIDRUG RESISTANCE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NONHUMAN; PHENOTYPE; PROGNOSIS; RISK ASSESSMENT;

EID: 33645521223     PISSN: 02550857     EISSN: 02550857     Source Type: Journal    
DOI: 10.4103/0255-0857.19893     Document Type: Article

References (25)

1. Bergogue-Berezin E, Towner KJ. Acinetobacter species as nosocomial pathogen:Microbiological, clinical and epidemiological features. Clin Microbiol Rev 1996;9:148-65.
2. Mittal N, Nair D, Gupta N, Rawat D, Kabra S, Kumar S, et al. Outbreak of Acinetobacter spp septicemia in a neonatal ICU. Southeast Asian J Trop Med Public Health 2003 ;34:365-6.
3. Seifert H, Strate A, Pulverer G. Nosocomial bacteremia due to Acinetobacter baumannii:clinical features, epidemiology, and predictors of mortality. Medicine 1995;74:340-9.
4. Cisneros JM, Reyes MJ, Pachón J, Becerril B, Caballero FJ, Garcia-Garmendia JL, et al. 1996. Bacteremia due to Acinetobacter baumannii:epidemiology, clinical findings and prognostic features. Clin Infect Dis 1996;22:1026-32.
5. Gómez J, Simmarro E, Banos V, Requena L, Ruiz J, Gracia F, et al. Six-year prospective study of risk and prognostic factors in patients with nosocomial sepsis caused by Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis 1999;18:358-61.
6. Kapil A, Gulati S, Goel V, Kumar L, Krishnan R, Kochupillai V. Outbreak of nosocomial Acinetobacter baumannii bacteremia in a high risk ward. Med Oncol 1998;15:270-4.
7. Lortholary O, Fagon JY, Hoy AB, Slama MA, Pierre J, Giral P, et al. Nosocomial acquisition of multiresistant A. baumannii:risk factors and prognosis. Clin Infect Dis 1995;20:790-6.
8. Forster DH, Daschner FD. Acinetobacter species as nosocomial pathogens. Eur J Clin Microbiol Infect Dis 1998;17:73-7.
9. Rello J. Acinetobacter baumannii infections in the ICU: customization is the key. Chest 1999;115:1226-9.
10. Suri A, Mahapatra AK, Kapil A. Acinetobacter infection in neurosurgical intensive care patients. Natl Med J India 2000;13:296-300.
11. Gerner-Smidt P. Acinetobacter: Epidemiological and taxonomic aspects. Acta Pathol Microbiol Immunol Scand 1994;47:1-41.
12. Bouvet PJM, Grimont PAD. Identification and biotyping of clinical isolates of Acinetobacter. Ann Institut Pasteur Microbiol 1987;138:569-78.
13. Prashanth K, Badrinath S. Simplified phenotypic tests for identification of Acinetobacter spp. and their antimicrobial susceptibility status. J Med Microbiol 2000;49:773-8.
14. National Committee for Clinical Laboratory Standards:Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard M7-A4. NCCLS, Wayne, PA: 2000.
15. Prashanth K, Badrinath S. In vitro susceptibility pattern of clinically significant Acinetobacter species to commonly used cephalosporins, quinolones, and aminoglysocides. Indian J Medical Microbiol 2004;22:97-103.
16. D'Agata EM, Thayer V, Schaffner W. An outbreak of Acinetobacter baumannii:the importance of cross-transmission. Infect Control Hasp Epiclemiol 2000;21:588-91.
17. Sofianou DC, Constandinidis TC, Yannacou M, Anastasiou H, Sofianos E. Analysis of risk factors for ventilator-associated pneumonia in a multidisciplinary Intensive care unit. Eur J Clin Microbiol Infect Dis 2000;19:460-3.
18. Peacock JE, Sorrell L, Sottile FD, Price LE, Rutula WA. Nosocomial respiratory tract colonization and infection with aminoglycoside-resistant Acinetobacter calcoaceticus var. anitratus:epidemiologic characteristics and clinical significance. Infect Control Hosp Epidemiol 1998;9:302-8.
19. Fagon JY, Chaste J, Domart Y, Trouillet JL, Gilbert C. Mortality due to ventilator associated pneumonia or colonization with Pseudomonas or Acinetobacter spp:assessment by quantitative culture of samples obtained by a protected specimen brush. Clin Infect Dis 1996;23:538-42.
20. Tilley PA, Roberts, FJ. Bacteremia with Acinetobacter species:risk factors and prognosis in different clinical settings. Clin Infect Dis 1994;18:896-900.
21. Tjernberg I, Ursing J. Clinical strains of Acinetobacter classified by DNA-DNA hybridization. Acta Pathol Microbiol Immunol Scand 1989;97:595-605.
22. Ku SC, Hsueh PR, Yang PC, Luh KT. Clinical and microbiological characteristics of bacteremia caused by Acinetobacter lwoffii. Eur J Clin Microbiol Infect Dis 2000;19:501-5.
23. Pandian JD, Sarada C, Radhakrishnan W, Kishore A. Iatrogenic meningitis after lumbar puncture - a preventable health hazard. J Hosp Infect 2004;56:119-24.
24. Prashanth K, Madhavaranga MP, Rao VA, Kanungo R. Corneal perforation due to Acinetobacter junii:a case report. Diagn Microbiol Infect Dis 2000;37:215-7.
25. Gulati S, Kapil A, Goel V, Das B, Dwivedi SN, Mahapatra AK. Biotyping of Acinetobacter species isolated from clinical samples. Indian J Med Res 1999;110:160-3.